Jump Financial, LLC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1831577 Chicago, IL

Position in FULC

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$2,836,403

+$1,793,621 QoQ

Shares Held

369,805

+301.1% QoQ

Ownership

0.555%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#34

of 168 holders

Holding Since

Jun 2021

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Jump Financial, LLC holds $252,735,812 across 133 Biotechnology names. FULC ranks #28 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	206,675	$15,519,225
2	APLS	Apellis Pharmaceuticals, Inc.	291,488	$11,726,562
3	SRPT	Sarepta Therapeutics, Inc.	507,828	$11,050,335
4	DAWN	Day One Biopharmaceuticals, Inc.	497,365	$10,663,505
5	RARE	Ultragenyx Pharmaceutical Inc.	504,143	$10,561,795
6	LEGN	Legend Biotech Corp	516,633	$9,345,890
7	XENE	Xenon Pharmaceuticals Inc.	155,776	$9,058,374
8	BNTX	BioNTech SE	79,189	$7,038,317

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,836,403	369,805	+301.1%	Shares	Defined	2026-05-14
2025-12-31	$1,042,782	92,200	+773.9%	Shares	Defined	2026-02-17
2025-03-31	$30,384	10,550	-88.8%	Shares	Defined	2025-05-14
2024-06-30	$583,922	94,181	+205.3%	Shares	Defined	2024-11-14
2024-03-31	$291,167	30,844	-66.4%	Shares	Sole	2024-05-13
2023-09-30	$407,547	91,790	+216.5%	Shares	Sole	2023-11-07
2022-06-30	$142,100	29,000	+166.5%	Shares	Sole	2022-08-09
2021-12-31	$192,502	10,882	-14.3%	Shares	Sole	2022-02-10
2021-06-30	$133,085	12,699	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.